CAR-T Followed by Bispecific Antibodies

Clinical trial NCT04889716 · RECRUITING

Trial details

NCT number: NCT04889716
Sponsor: Abramson Cancer Center at Penn Medicine
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Large B-cell Lymphoma DLBCL - Diffuse Large B Cell Lymphoma

Start date: 2021-11-05
Primary completion: 2027-12-31
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.